ASCO 2014 melanoma

Описание: The full CME-certified video is available here:
http://www.primeoncology.org/online_e...

Jeffrey S. Weber, MD, PhD and Robert E. Coleman, MD, FRCP, FRCPE; discuss newly released abstracts in melanoma from the ASCO 2014 meeting

Abstract #LBA9008:
Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safety results from the EORTC 18071 phase III trial

Abstract #LBA9000:
Efficacy and safety of the anti-PD-1 monoclonal antibody MK-3475 in 411 patients (pts) with melanoma (MEL)

Abstract #9002:
Long-term survival of ipilimumab-naïve patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial

Abstract #LBA9003:
Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL).